Dana-Farber Cancer Institute
Avatar

The PROMISE of Early Detection and Interception in Myeloma

By Dana-Farber Cancer Institute FEATURING Irene Ghobrial
By Dana-Farber Cancer Institute FEATURING Irene Ghobrial
0 views
March 9, 2023
Comments 0
Login to view comments. Click here to Login

Featured Video

24:35
Indy Hematology Review

Current Approaches in the Treatment of Myeloproliferative Neoplasms

Feat. A. Tefferi

Featured Video

16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison

Recommended

AUTOPLAY
25:23
Houston Methodist Hospital

Whole-Body MRI: Past, Present, and Future

Feat. N. Gupta
19:08
Insights from 2023 ASH Annual Meeting

ASH 2023 Summary: "Practice Changing Updates in MM, SMM and MGU…

Feat. R. Banerjee
18:51
Dana-Farber Cancer Institute

Multiple Myeloma 101: Diagnosis, Prognosis, and Risk

Feat. P. Richardson
32:06
Scripps Health

Should Patients With High-Risk SMM Be Treated Outside a Clinical Tri…

Feat. M. Gertz
35:27
Dana-Farber Cancer Institute

Advances in Multiple Myeloma 2024: From Bench to Bedside

Feat. K. Anderson
15:36
Memorial Sloan Kettering Cancer Center

Key Myeloma & MGUS Updates From ASH

Feat. S. Mailankody
28:20
PleXus Communications

Why We Should Not Treat SMM

Feat. B. Derman
04:15
Indy Hematology Review

Indy Hematology Review 2023: Plasma Cell Neoplasms and Amyloidosis U…

Feat. M. Gertz
23:34
MyCancerHaven

Experts Discuss the Diagnosis and Management of High-Risk Multiple M…

Feat. R. Vij, M. Alsina
11:55
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "CENTAURUS Study Final Analysis - Efficacy &…

Feat. O. Landgren
32:03
Indy Hematology Review

Emerging and Current Treatment of MM: What Should We Know and What S…

Feat. K. Anderson
41:54
University of Colorado Division of Hematology

Overview of Pathophysiology, Diagnosis and Management of Multiple My…

Feat. K. Sidor
19:56
Yale Cancer Center

Frontline Treatment Strategies in MM: A Comprehensive Overview of Cl…

Feat. T. Parker
52:39
Yale Cancer Center

Myeloma in 2023: So Many Drugs, Yet So Few Cures

Feat. A. Chari
22:15
5th SOHO Italy Annual Conference

SOHO Italy 2023: Multiple Myeloma Cured in 2030 - What Are the Next …

Feat. K. Anderson
25:52
Rush University Medical Center

CAR-T vs. Bispecific Antibodies in R/R MM: Insights and Future Direc…

Feat. A. Suvannasankha
10:23
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "iStopMM Study - Revised Definition of Free …

Feat. T. Einarsson Long
26:24
Dana-Farber Cancer Institute

Myeloma 101: Diagnosis, Prognosis & Risk

Feat. N. Munshi
15:21
MyCancerHaven

Response Assessment and Utility of MRD in Multiple Myeloma

Feat. R. Vij, A. Rossi
42:37
University of Colorado Department of Medicine

Multiple Myeloma in 2023: An Oncological Success Story

Feat. P. Forsberg